Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01346267 · ClinicalTrials.gov registry record · NA
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
A NA study of Unspecified Childhood Solid Tumor, Protocol Specific and Chemotherapy-induced Nausea and Vomiting, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
- 20
- Study locations
NCT01346267 is a NA study of Unspecified Childhood Solid Tumor, Protocol Specific and Chemotherapy-induced Nausea and Vomiting that has completed, run by University of South Florida. The registered enrollment target is 187 participants, below the 1,623-participant average among 13 other Unspecified Childhood Solid Tumor, Protocol Specific trials with a reported enrollment target (88% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT01346267, a NA study of Unspecified Childhood Solid Tumor, Protocol Specific and Chemotherapy-induced Nausea and Vomiting, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Acupressure wristbands may prevent or reduce nausea and caused by chemotherapy. It is not yet known whether standard care is more effective with or without acupressure wristbands in controlling acute and delayed nausea. PURPOSE: This randomized phase III trial is studying how well acupressure wristbands work with or without standard care in controlling nausea in young patients receiving highly emetogenic chemotherapy.
Conditions Studied
Interventions
- PROCEDURE Real Acupressure Band
- PROCEDURE Placebo Acupressure Band
Study Locations (20)
Florida
- Children's Hospital of Southwest Florida at Lee Memorial - Fort Myers
- Nemours Children's Clinic - Jacksonville
- Palms West Hospital - Loxahatchee Groves
- Nemours Children's Clinic - Orlando - Orlando
- Nemours Children's Clinic - Pensacola - Pensacola
- All Children's Hospital - St. Petersburg
- Tampa General Hospital - Tampa
California
- Miller Children's Hospital - Long Beach
- Childrens Hospital Los Angeles - Los Angeles
Connecticut
- Connecticut Children's Medical Center - Hartford
Delaware
- A I duPont Hospital for Children - Wilmington
District of Columbia
- Childrens National Medical Center - Washington D.C.
Hawaii
- Kapiolani Medical for Women and Children - Honolulu
Louisiana
- Ochsner Clinic Foundation New Orleans - New Orleans
Massachusetts
- Dana Farber Cancer Institute at Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2011-05 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01346267
The ClinicalTrials.gov registry entry for NCT01346267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,623-participant average among 13 other Unspecified Childhood Solid Tumor, Protocol Specific trials with a reported enrollment target (88% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Unspecified Childhood Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 2 interventions - of which Real Acupressure Band is the first listed.
NCT01346267 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT01346267 about?
NCT01346267 is a clinical study titled "Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy". RATIONALE: Acupressure wristbands may prevent or reduce nausea and caused by chemotherapy. It is not yet known whether standard care is more effective with or without acupressure wristbands in controlling acute and delayed nausea. PURPOSE: This randomized phase III trial is studying how well acupre...
What is the current status of trial NCT01346267?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2011-05. Estimated completion is 2016-05.
What conditions does trial NCT01346267 study?
This clinical trial studies the following conditions: Unspecified Childhood Solid Tumor, Protocol Specific, Chemotherapy-induced Nausea and Vomiting, Central Nervous System Tumor, Pediatric.
What interventions are being tested in trial NCT01346267?
The interventions under investigation include: Real Acupressure Band (PROCEDURE), Placebo Acupressure Band (PROCEDURE).
Who is sponsoring clinical trial NCT01346267?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01346267 being conducted?
This trial has 20 study locations across California, Connecticut, Delaware, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unspecified Childhood Solid Tumor, Protocol Specific
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants
COMPLETED · NA
-
Pharmacokinetics of Daunorubicin in Young Patients With Cancer
COMPLETED · NA
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
RECRUITING
-
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
COMPLETED · Phase 2
-
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
COMPLETED · Phase 1
-
Bevacizumab in Treating Young Patients With Refractory Solid Tumors
COMPLETED · Phase 1
Explore more on PlainTrial
Unspecified Childhood Solid Tumor, Protocol Specific
All registered trials for this condition
Chemotherapy-induced Nausea and Vomiting
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.